FDC Q4 FY16 earnings call: Revenue & Margins
Q4 FY16 investor presentation: what the company reported on revenue, margins and capex.
Top 10 Pharmaceuticals & Biotechnology companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on FDC Ltd's Q4 FY16 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Quarter Revenue (Q4 FY 2016 vs Q4 FY 2015): Total revenue about Rs. 845 Cr with about 11.4% primary internal sales growth noted for the full FY 2016; Q4 FY 2016 total revenue higher than Q4 FY 2015.
From FDC Ltd's Q4 FY16 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Quarter Revenue (Q4 FY 2016 vs Q4 FY 2015): Total revenue about Rs. 845 Cr with about 11.4% primary internal sales growth noted for the full FY 2016; Q4 FY 2016 total revenue higher than Q4 FY 2015 (Rs. 760 Cr approx.), indicating positive growth.
- Year-on-Year Growth: Secondary sales growth of 9.1% for FDC Limited in FY 2016; FDC ranked 25th with market share of 0.96%; Primary internal sales grew 11.4% Apr ’15 to Mar ‘16.
Profitability & Margins
See what FDC Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what FDC Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what FDC Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what FDC Ltd said on order book & pipeline — free account, 30 seconds.
FDC Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹572 Cr, net profit ₹49 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What FDC's management said in earlier quarters
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
FDC Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were FDC Ltd Q4 FY16 results?
Quarter Revenue (Q4 FY 2016 vs Q4 FY 2015): Total revenue about Rs. 845 Cr with about 11.4% primary internal sales growth noted for the full FY 2016; Q4 FY 2016 total revenue higher than Q4 FY 2015.
What is FDC Ltd share price analysis?
FDC Ltd currently shows a neutral. The stock trades at a P/E of 18.6 with a market cap of ₹5,739 Cr. Investors should review the full earnings analysis for detailed insights.
Keep FDC Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.